Clinical trials such as the STEP programme (semaglutide) and SUSTAIN studies show that: Initial weeks : Modest weight loss primarily from reduced caloric intake Months 23 : More noticeable reduction becomes evident Months 36 : Continued steady weight loss as dose escalates Months 612 : Peak weight loss approaches, with most studies showing maximal effect by 1218 months It is important to recognise that GLP-1 medications require dose titration starting at a low dose and gradually increasing over several weeks according to the specific product's SmPC
Responsible use of this medication is key, and our team is able to safely monitor this medication as part of our protocol says Dr
Staying hydrated, getting enough sleep, and following a consistent Tirzepatide injection schedule can further enhance its effectiveness
Efficacy and safety of semaglutide versus dulaglutide as add-on to metformin and/or sulfonylurea in subjects with type 2 diabetes (SUSTAIN 7): a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Regular monitoring and adjustments, outlined in the template, help optimize the weight loss effects while minimizing potential side effects
